Dellora Investments LP - 13 Dec 2024 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role: no longer 10% owner
Signature: Dellora Investments LP, /s/ Kevin Pyun, Principal, Dellora Investments GP LLC, its General Partner
Issuer symbol: PVLA
Transactions as of: 13 Dec 2024
Net transactions value: $0
Form type: 4
Filing time: 16 Dec 2024, 16:18:07 UTC
Previous filing: 18 Nov 2024
Next filing: 10 Jan 2025
SEC: View on sec.gov

Dellora Investments LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Palvella Therapeutics, Inc. is the successor to Pieris Pharmaceuticals, Inc.. After the closing of the merger and financing on 12/13/2024, Dellora Investments LP is no longer a 10% shareholder in the reporting company.